Alpers' disease

Jump to navigation Jump to search
Alpers' disease
ICD-10 G31.8
ICD-9 330.8
OMIM 203700
DiseasesDB 29298
MeSH D002549

WikiDoc Resources for Alpers' disease

Articles

Most recent articles on Alpers' disease

Most cited articles on Alpers' disease

Review articles on Alpers' disease

Articles on Alpers' disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alpers' disease

Images of Alpers' disease

Photos of Alpers' disease

Podcasts & MP3s on Alpers' disease

Videos on Alpers' disease

Evidence Based Medicine

Cochrane Collaboration on Alpers' disease

Bandolier on Alpers' disease

TRIP on Alpers' disease

Clinical Trials

Ongoing Trials on Alpers' disease at Clinical Trials.gov

Trial results on Alpers' disease

Clinical Trials on Alpers' disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alpers' disease

NICE Guidance on Alpers' disease

NHS PRODIGY Guidance

FDA on Alpers' disease

CDC on Alpers' disease

Books

Books on Alpers' disease

News

Alpers' disease in the news

Be alerted to news on Alpers' disease

News trends on Alpers' disease

Commentary

Blogs on Alpers' disease

Definitions

Definitions of Alpers' disease

Patient Resources / Community

Patient resources on Alpers' disease

Discussion groups on Alpers' disease

Patient Handouts on Alpers' disease

Directions to Hospitals Treating Alpers' disease

Risk calculators and risk factors for Alpers' disease

Healthcare Provider Resources

Symptoms of Alpers' disease

Causes & Risk Factors for Alpers' disease

Diagnostic studies for Alpers' disease

Treatment of Alpers' disease

Continuing Medical Education (CME)

CME Programs on Alpers' disease

International

Alpers' disease en Espanol

Alpers' disease en Francais

Business

Alpers' disease in the Marketplace

Patents on Alpers' disease

Experimental / Informatics

List of terms related to Alpers' disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Alpers' disease, also called Alpers' syndrome,[1] progressive neuronal degeneration of childhood,[1] progressive sclerosing poliodystrophy, and progressive infantile poliodystrophy, is a progressive degenerative disease of the central nervous system that occurs in infants and children. It is an autosomal recessive disorder that is sometimes seen in siblings.

Classification

  • There is no established system for the classification of Alpers disease.

Pathophysiology

Causes

Differentiating Alpers disease from other Diseases

Epidemiology and Demographics

  • The prevalence of Alpers disease is approximately 1 per 100,000 individuals worldwide.
  • Alpers disease affects men and women equally.
  • Higher carrier frequency is seen in the Northern European population.[3]

Risk Factors

  • There are no established risk factors for Alpers disease.

Screening

  • There is insufficient evidence to recommend routine screening for Alpers disease.

Natural History, Complications, and Prognosis

  • Prognosis is generally poor,

Prognosis

The prognosis for individuals with Alpers' disease is poor. Those with the disease usually die within their first decade of life. Liver failure is usually the cause of death, although cardiorespiratory failure may also occur.

Eponym

It is named for Bernard Jacob Alpers.[7][8][9]

Notes

  1. 1.0 1.1 Naudé, J te Water, C M Verity, R G Will, G Devereux, and L Stellitano. (2004.) "Is variant Creutzfeldt-Jakob disease in young children misdiagnosed as Alpers’ syndrome? An analysis of a national surveillance study" Journal of Neurology Neurosurgery and Psychiatry, 2004;75:910-913. (Fee for full text.) Retrieved on 2007-09-27.
  2. Copeland WC (2012). "Defects in mitochondrial DNA replication and human disease". Crit Rev Biochem Mol Biol. 47 (1): 64–74. doi:10.3109/10409238.2011.632763. PMC 3244805. PMID 22176657.
  3. 3.0 3.1 Saneto RP, Cohen BH, Copeland WC, Naviaux RK (2013). "Alpers-Huttenlocher syndrome". Pediatr Neurol. 48 (3): 167–78. doi:10.1016/j.pediatrneurol.2012.09.014. PMC 3578656. PMID [1] 23419467]] Check |pmid= value (help).
  4. Qian Y, Ziehr JL, Johnson KA (2015). "Alpers disease mutations in human DNA polymerase gamma cause catalytic defects in mitochondrial DNA replication by distinct mechanisms". Front Genet. 6: 135. doi:10.3389/fgene.2015.00135. PMC 4391263. PMID 25914719.
  5. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K; et al. (1993). "GeneReviews®". PMID 20301791.
  6. Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C; et al. (2008). "Molecular and clinical genetics of mitochondrial diseases due to POLG mutations". Hum Mutat. 29 (9): E150–72. doi:10.1002/humu.20824. PMC 2891192. PMID 18546365.
  7. Template:WhoNamedIt
  8. Template:WhoNamedIt
  9. B. J. Alpers. Diffuse progressive degeneration of the grey matter of the cerebrum. Archives of Neurology and Psychiatry, Chicago, 1931, 25: 469-505.

References

"Alpers' Disease Information Page". (Website). National Institute of Neurological Disorders and Stroke, U.S. National Institutes of Health.

Template:Diseases of the nervous system

fi:Alpersin tauti

Template:WS